FDA-cleared profile

V5med Lung AI

V5med Inc. · CT/CTA · FDA-cleared (510(k))

Authorized purpose: V5med Lung AI provides concurrent-read adjunctive notification of suspected pulmonary nodules on chest CT; it does not replace radiologist judgment, diagnostic processes, or review of original CT series.

Clinical role
Detection, localization, or diagnostic support
Images and patients
CT/CTA · Chest/Lung
Key limitation
Keep in mind: The device is for concurrent reading and is not to be used in isolation from the original CT series or as a replacement for diagnosis.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: V5med Lung AI provides concurrent-read adjunctive notification of suspected pulmonary nodules on chest CT; it does not replace radiologist judgment, diagnostic processes, or review of original CT series.
  • Which images or clinical context are in scope?Modality: CT/CTA Anatomy or clinical context: Chest/Lung Input: DICOM chest CT accepted from PACS, RIS, or directly from a CT scanner, including multi-detector scanners from Siemens, GE, Philips, and Toshiba.
  • Who uses it?Intended users: Radiologists.
  • What does the software produce?Output: DICOM GSPS annotations with bounding boxes around detected 4-30 mm lung nodules; original CT images are retained.
  • What is its most important limitation?Key limitation: The device is for concurrent reading and is not to be used in isolation from the original CT series or as a replacement for diagnosis.

Clinical takeaway. Clinical role: V5med Lung AI provides concurrent-read adjunctive notification of suspected pulmonary nodules on chest CT; it does not replace radiologist judgment, diagnostic processes, or review of original CT series.

Evidence takeaway. Evidence from the reviewed source record: A retrospective fully crossed multi-reader, multi-case study used 340 chest CT cases reviewed by 16 board-certified radiologists; screening and nonscreening CT were included.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
V5med Lung AI provides concurrent-read adjunctive notification of suspected pulmonary nodules on chest CT; it does not replace radiologist judgment, diagnostic processes, or review of original CT series.
  • Exact FDA submission
  • Checked 2026-09-05
Workflow role
Detection, localization, or diagnostic support
  • Exact FDA submission
  • Checked 2026-09-05
Required input
DICOM chest CT accepted from PACS, RIS, or directly from a CT scanner, including multi-detector scanners from Siemens, GE, Philips, and Toshiba.
  • Exact FDA submission
  • Checked 2026-09-05
Output and clinician action
DICOM GSPS annotations with bounding boxes around detected 4-30 mm lung nodules; original CT images are retained.
  • Exact FDA submission
  • Checked 2026-09-05
Care setting
Asymptomatic populations undergoing chest CT.
  • Exact FDA submission
  • Checked 2026-09-05
Intended users
Radiologists.
  • Exact FDA submission
  • Checked 2026-09-05
Limitations
The device is for concurrent reading and is not to be used in isolation from the original CT series or as a replacement for diagnosis.
  • Exact FDA submission
  • Checked 2026-09-05
Evidence summary
A retrospective fully crossed multi-reader, multi-case study used 340 chest CT cases reviewed by 16 board-certified radiologists; screening and nonscreening CT were included.
  • Exact FDA submission
  • Checked 2026-09-05

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
A retrospective fully crossed multi-reader, multi-case study used 340 chest CT cases reviewed by 16 board-certified radiologists; screening and nonscreening CT were included.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Reported sensitivity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-05

No complete numerical sensitivity endpoint was abstracted.

Reported specificity
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-05

No complete numerical specificity endpoint was abstracted.

No contextualized exact-version metric has completed evidence review. Regulatory-document values, when available, are shown above with their limitations.

V5med Lung AI K242919 reader study

  • DesignRetrospective fully crossed multi-reader, multi-case study
  • Population340 screening and nonscreening chest CT cases; 16 board-certified radiologists
  • Scopeexact submission
  • Tested versionV5-LU01 submitted in K242919; build not stated
  • Samplen=340
  • IndependenceIndependence not established

K242919

The FDA summary describes LROC/AUC comparison with and without AI; no numerical endpoints were carried forward without complete extracted context.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
Not established in reviewed sources
  • Reviewed sources checked
  • Exact FDA submission
  • Checked 2026-09-04

No native submission-identifier match was found in the checked openFDA radiology recall snapshot. Product-name, manufacturer, and adverse-event searches remain necessary; this does not establish that no recall or safety report exists.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not verified: Pricing information is recorded but not verified against a resolving source.

Reimbursement

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: DICOM chest CT accepted from PACS, RIS, or directly from a CT scanner, including multi-detector scanners from Siemens, GE, Philips, and Toshiba.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-05 · FDA 510(k) K242919: V5med Lung AI

  2. Routing

    Source context, not route validation: PACS, RIS, and direct CT input are described; results are emitted as DICOM GSPS.

    Scope: Exact FDA submission. Specific interface versions and site compatibility require confirmation.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-05 · FDA 510(k) K242919: V5med Lung AI

  3. AI processing

    Source context, not route validation: The exact FDA package describes V5med Lung AI as a system that integrates algorithm logic and database on the same server. Current hosting, data flow, and commercial configuration require vendor confirmation.

    Scope: Exact FDA submission. Packet wording: "The system integrates algorithm logic and database on the same server, ensuring simplicity and ease of maintenance.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-11-14 · FDA 510(k) K242919: V5med Lung AI

  4. Returned objects

    Source context, not route validation: DICOM GSPS annotations with bounding boxes around detected 4-30 mm lung nodules; original CT images are retained.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-05 · FDA 510(k) K242919: V5med Lung AI

  5. Viewer/worklist/report

    Unresolved route: DICOM GSPS annotations with bounding boxes around detected 4-30 mm lung nodules; original CT images are retained.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-05 · FDA 510(k) K242919: V5med Lung AI

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Deployment
The exact FDA package describes V5med Lung AI as a system that integrates algorithm logic and database on the same server. Current hosting, data flow, and commercial configuration require vendor confirmation.
  • Exact FDA submission
  • Checked 2026-11-14

Packet wording: "The system integrates algorithm logic and database on the same server, ensuring simplicity and ease of maintenance.". Read from the exact FDA decision document on 2026-11-14; this is the release-level description, not current commercial configuration.

Integration
PACS, RIS, and direct CT input are described; results are emitted as DICOM GSPS.
  • Exact FDA submission
  • Checked 2026-09-05

Specific interface versions and site compatibility require confirmation.

Current product-family nodule workflow

The vendor describes serial-nodule comparison, volume-doubling-time and report-support functions.

product family · checked 2026-09-05

These current product-family claims are not evidence that every function was in the K242919 configuration.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K242919
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
CT/CTA
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Anatomy
Chest/Lung
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-05
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2025-03-27
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-05Last searched
22Fields reviewed
11Source classes checked
0Screened PubMed leads
1Screened trial leads
0Unreviewed FDA recall leads

Stored trial metadata was screened. NCT06514248 is a V5-LU01 thoracic CT record; the direct registry page was not readable and exact configuration/protocol linkage was not established, so no study result was promoted. No stored PubMed candidates. The current discovery snapshot contains 0 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, fda decision material, vendor product page, literature index, trial registry, fda device recall, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not verified - checked 2026-09-06 - Exact FDA submission

    No scoped public price or procurement award was reviewed.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Reimbursement: Not publicly available - checked 2026-10-26 - Exact FDA submission

    Bounded web search on 2026-10-26 (query: "V5med Lung AI reimbursement CPT"; top results reviewed) found no vendor or payer page stating coding, coverage or payment for this product. This records what was found, not that none exists.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not verified - checked 2026-09-06 - Exact FDA submission

    No dated, scoped security documentation was reviewed.

  • Installation timeline: Not yet reviewed
  • Training: Not verified - checked 2026-09-06 - Exact FDA submission

    Current training/support commitments were not established.

  • Monitoring: Not verified - checked 2026-10-27 - Exact FDA submission

    Current drift, quality, uptime, alert, escalation, and incident-response commitments for the exact configuration require vendor confirmation.

7 sources - 3 history items

Source ledger

  1. FDA 510(k) K242919: V5med Lung AI

    U.S. Food and Drug Administration - Published 2025-03-27 - Accessed 2026-09-05

    Scope: identity, clinicalUse, modality, anatomy, input, output, limitations, integration, evidenceSummary, deployment

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. V5med Lung AI model card (K242919)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, output, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

  7. V5med Lung AI

    V5med Inc. - Accessed 2026-09-05

    Scope: productFamilyWorkflow, implementationCapabilities

Research history

  1. K242919 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K251474

Median LCS (internal name) / eyonis LCS (trade name) (1.0)

Median Technologies

eyonis LCS is a concurrent-reading aid for radiologists that detects, localizes, and characterizes 4-30 mm solid and part-solid pulmonary nodules on low-dose chest CT images for high-risk lung cancer screening patients; it provides nodule measurements and malignancy scores and does not replace physician judgment.

Modality
CT/CTA
Anatomy
Chest/Lung
Decision
2026-02-06
FDA-cleared K231157

syngo.CT Lung CAD (Version VD30)

Siemens Healthcare GmbH

Authorized purpose: Assist radiologists in detecting solid and subsolid pulmonary nodules during review of multivendor multi-detector CT examinations of the chest; the device is an adjunctive first- or second-reader tool.

Modality
CT/CTA
Anatomy
Chest/Lung
Decision
2023-07-19

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history